4//SEC Filing
Sheridan John F 4
Accession 0001438133-25-000085
CIK 0001438133other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 6:06 PM ET
Size
26.3 KB
Accession
0001438133-25-000085
Insider Transaction Report
Form 4
Sheridan John F
EXECUTIVE VP AND COO
Transactions
- Exercise/Conversion
Common Stock
2025-05-15+792→ 81,160 total - Tax Payment
Common Stock
2025-05-15$22.70/sh−1,136$25,787→ 81,857 total - Exercise/Conversion
Common Stock
2025-05-15$22.70/sh+5,472$124,214→ 87,329 total - Tax Payment
Common Stock
2025-05-15$22.70/sh−12,152$275,850→ 96,327 total - Exercise/Conversion
Restricted Stock Unit
2025-05-15−2,236→ 0 total→ Common Stock (2,236 underlying) - Tax Payment
Common Stock
2025-05-15$22.70/sh−403$9,148→ 80,757 total - Exercise/Conversion
Common Stock
2025-05-15+23,929→ 108,479 total - Exercise/Conversion
Restricted Stock Unit
2025-05-15−5,472→ 21,886 total→ Common Stock (5,472 underlying) - Award
Common Stock
2025-05-15$15.64/sh+1,359$21,255→ 80,368 total - Exercise/Conversion
Common Stock
2025-05-15+2,236→ 82,993 total - Tax Payment
Common Stock
2025-05-15$22.70/sh−2,779$63,083→ 84,550 total - Exercise/Conversion
Restricted Stock Unit
2025-05-15−792→ 0 total→ Common Stock (792 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-05-15−23,929→ 47,858 total→ Common Stock (23,929 underlying)
Footnotes (12)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2024, through May 15, 2025. This transaction is also exempt under Rule 16b-3(c).
- [F10]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
- [F11]Awarded on May 23, 2024 pursuant to the 2023 Plan.
- [F12]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
- [F2]Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
- [F3]Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
- [F4]Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
- [F5]RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
- [F6]Awarded on May 25, 2022 pursuant to the 2013 Plan.
- [F7]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
- [F8]Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- [F9]Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
Documents
Issuer
TANDEM DIABETES CARE INC
CIK 0001438133
Entity typeother
Related Parties
1- filerCIK 0001365369
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 6:06 PM ET
- Size
- 26.3 KB